Prostate cancer: NICE issues an updated quality standard

  • NICE

  • curated by Pavankumar Kamat
  • UK Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

The National Institute for Health and Care Excellence (NICE) has issued an updated quality standard focusing on managing prostate cancer in individuals referred to secondary care or being followed-up in primary care, with respect to high-quality care in priority areas for improvement.

The key goals of the quality standard are improvements in the following areas:

  • Quality of life
  • Care and support needs
  • Premature mortality from prostate cancer
  • Patient experience of hospital care

The updated quality standard covers the following 5 recommendations:

  1. Individuals with prostate cancer should discuss treatment options and adverse effects with a named nurse specialist.
  2. Individuals with low-risk localised prostate cancer suitable for radical treatment should be offered to choose among active surveillance, radical prostatectomy or radical radiotherapy.
  3. Individuals intermediate- or high-risk localised prostate cancers suitable for non-surgical radical treatment should be offered a combination of radical radiotherapy and androgen deprivation therapy.
  4. Individuals experiencing treatment-related adverse effects should be referred to specialist services.
  5. Individuals with hormone-relapsed metastatic prostate cancer should have their treatment options reviewed by a urological cancer multidisciplinary team.

Health professionals should also take into consideration the quality standards on Suspected cancer, Bladder cancer, Lower urinary tract symptoms in men, Patient experience in adult NHS services and End of life care for adults when providing services for prostate cancer.